Amgen Inc. (AMGN) Earnings History
Profitable38 years of earnings data (1988–2025) · Positive TTM net income
Loading earnings history...
Amgen Inc. (AMGN) Earnings Overview
As of June 21, 2026, Amgen Inc. (AMGN) reported trailing twelve-month net income of $7.80B, reflecting +88.2% year-over-year growth. The company earned $14.34 per diluted share over the past four quarters, with a net profit margin of 21.0%.
Looking at the long-term picture, AMGN's 5-year EPS compound annual growth rate (CAGR) stands at +2.9%, reflecting modest earnings expansion. The company achieved its highest annual net income of $8.39B in fiscal 2018.
Amgen Inc. maintains industry-leading profitability with a gross margin of 70.8%, operating margin of 29.1%, and net margin of 21.0%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including GILD ($9.22B net income, 28.9% margin), BIIB ($1.37B net income, 13.2% margin), REGN ($4.42B net income, 31.4% margin), AMGN has room to improve margins relative to the peer group. Compare AMGN vs GILD →
AMGN Earnings vs Peers
Earnings metrics vs comparable public companies
AMGN Historical Earnings Data (1988–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $7.71B | +88.5% | $10.68B | $14.23 | 21.0% | 29.1% |
| 2024 | $4.09B | -39.1% | $7.26B | $7.56 | 12.2% | 21.7% |
| 2023 | $6.72B | +2.5% | $7.90B | $12.49 | 23.8% | 28.0% |
| 2022 | $6.55B | +11.2% | $9.57B | $12.11 | 24.9% | 36.3% |
| 2021 | $5.89B | -18.9% | $7.64B | $10.28 | 22.7% | 29.4% |
| 2020 | $7.26B | -7.4% | $9.14B | $12.31 | 28.6% | 35.9% |
| 2019 | $7.84B | -6.6% | $9.67B | $12.88 | 33.6% | 41.4% |
| 2018 | $8.39B | +324.2% | $10.26B | $12.62 | 35.3% | 43.2% |
| 2017 | $1.98B | -74.4% | $9.97B | $2.69 | 8.7% | 43.6% |
| 2016 | $7.72B | +11.3% | $9.79B | $10.24 | 33.6% | 42.6% |
| 2015 | $6.94B | +34.5% | $8.47B | $9.06 | 32.0% | 39.1% |
| 2014 | $5.16B | +1.5% | $6.19B | $6.70 | 25.7% | 30.9% |
| 2013 | $5.08B | +16.9% | $5.87B | $6.64 | 27.2% | 31.4% |
| 2012 | $4.34B | +18.0% | $5.58B | $5.52 | 25.2% | 32.3% |
| 2011 | $3.68B | -20.4% | $4.31B | $4.04 | 23.6% | 27.7% |
| 2010 | $4.63B | +0.5% | $5.54B | $4.79 | 30.7% | 36.8% |
| 2009 | $4.61B | +9.7% | $5.51B | $4.51 | 31.5% | 37.6% |
| 2008 | $4.20B | +32.5% | $5.21B | $3.77 | 28.0% | 34.8% |
| 2007 | $3.17B | +7.3% | $3.98B | $2.82 | 21.4% | 26.9% |
| 2006 | $2.95B | -19.7% | $3.84B | $2.48 | 20.7% | 26.9% |
| 2005 | $3.67B | +55.5% | $4.85B | $2.93 | 29.6% | 39.0% |
| 2004 | $2.36B | +4.6% | $3.35B | $1.81 | 22.4% | 31.7% |
| 2003 | $2.26B | +262.3% | $3.09B | $1.69 | 27.0% | 37.0% |
| 2002 | -$1.39B | -224.3% | -$785M | $-1.21 | -25.2% | -14.2% |
| 2001 | $1.12B | -1.7% | $1.53B | $1.03 | 27.9% | 38.1% |
| 2000 | $1.14B | +3.8% | $1.37B | $1.05 | 33.0% | 39.7% |
| 1999 | $1.10B | +27.0% | $1.32B | $1.02 | 34.2% | 41.4% |
| 1998 | $863M | +34.0% | $1.12B | $0.82 | 32.7% | 42.3% |
| 1997 | $644M | -5.2% | $930M | $0.59 | 27.5% | 39.7% |
| 1996 | $680M | +26.4% | $916M | $0.61 | 30.9% | 41.7% |
| 1995 | $538M | +68.2% | $761M | $0.47 | 28.2% | 40.0% |
| 1994 | $320M | -16.6% | $699M | $0.28 | 19.7% | 43.1% |
| 1993 | $383M | +7.2% | $551M | $0.35 | 28.3% | 40.7% |
| 1992 | $358M | +265.3% | $498M | $0.31 | 33.1% | 46.1% |
| 1991 | $98M | +412.6% | $123M | $0.09 | 14.4% | 18.2% |
| 1990 | $19M | +332.9% | $51M | $0.03 | 10.0% | 26.8% |
| 1988 | -$8M | - | -$5M | $-0.01 | -11.7% | -6.8% |
Download Data
Export AMGN earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into AMGN consensus models and risk factors.
Should I Buy AMGN?
Wall Street verdict, signals, and target summaries.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
38+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AMGN — Frequently Asked Questions
Quick answers to the most common questions about buying AMGN stock.
What is AMGN earnings per share (EPS)?
AMGN trailing twelve-month (TTM) diluted EPS is $14.34, reflecting +88.2% year-over-year growth. The 5-year EPS CAGR is +2.9%. Complete EPS history from 1988 to 2025 is available in the table on this page.
What is Amgen Inc.'s net income?
Amgen Inc. (AMGN) trailing twelve-month net income is $7.8B as of 2025. Earnings grew +88.2% year-over-year. Amgen Inc. has been profitable for 23 consecutive years.
Is AMGN profitable?
Yes, AMGN is profitable with a TTM net income of $7.8B and a net profit margin of +21.0%. Amgen Inc. has generated profits for 23 consecutive years.
What is AMGN's earnings growth rate?
AMGN compound annual EPS growth rates (CAGR): 1-Year: +88.2%, 3-Year: +5.5%, 5-Year: +2.9%, 10-Year: +4.6%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1988 to 2025.
What are AMGN's profit margins?
Amgen Inc. net profit margin is +21.0%, operating margin is +29.1%, and gross margin is +70.8%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +106.1%.
Is AMGN growing earnings?
Yes, AMGN earnings are accelerating — EPS growth of +88.2% exceeds the 5-year CAGR of +2.9%. TTM net income reached $7.8B. Earnings momentum is strengthening.
What was AMGN's best earnings year?
Amgen Inc.'s highest annual net income on record is $8.4B, achieved in fiscal year 2018. Earnings history on this page spans 1988 to 2025 and includes all annual and quarterly figures.
What were AMGN's earnings last quarter?
AMGN's most recent reported quarter was Q1 2026. Net income was $1.8B with diluted EPS of $3.34. For a full breakdown of all quarters, see the quarterly earnings table on this page.